CVSM
Elevation Series Trust - CresAlta Small and Mid-Cap ETF

0
Volume
20.00
52W High
$25.27
52W Low
$24.98
50D MA
$25.13
Prev Close
$24.98
Loading...
Loading...
News
all
press releases
Microsoft, Meta, Comcast and Biogen rise premarket; Qualcomm falls
Investing.com -- U.S. stock futures rose sharply Thursday, with investors digesting earnings from a couple of tech giants, the Federal Reserve policy decision and more labor market data.
investing.com·10mo ago
News Placeholder
More News
News Placeholder
Humana stock falls after losing Medicare bonus payment lawsuit
Investing.com -- Humana Inc (NYSE:HUM) stock fell as much as 7.5% before trimming losses to 4% following a court ruling against the health insurer in its Medicare bonus payment lawsuit. The decision also impacted other health insurers, with CVS Health (NYSE:CVS) and UnitedHealth Group (NYSE:UNH) shares declining 2%.
investing.com·10mo ago
News Placeholder
Centene stock tumbles after withdrawal of 2025 guidance
Investing.com -- Centene Corporation (NYSE:CNC) stock tumbled 20% after the health insurer withdrew its 2025 earnings guidance, citing unexpected challenges in its Health Insurance Marketplace business and rising Medicaid costs.
investing.com·11mo ago
News Placeholder
Mizuho updates U.S. top picks: Adds CVS Health, PayPal and Oracle
Investing.com -- Mizuho has updated its U.S. Top Picks list for June, adding CVS Health (NYSE:CVS), PayPal (NASDAQ:PYPL) and Oracle (NYSE:ORCL) to its highest-conviction ideas, alongside ConocoPhillips (NYSE:COP), First Solar (NASDAQ:FSLR), Insmed (NASDAQ:INSM), Corteva (NYSE:CTVA), and Carrier Global (NYSE:CARR). 
investing.com·1y ago
News Placeholder
UnitedHealth, Humana, CVS drop on expanded Medicare Advantage audits
Investing.com -- Shares of major health insurers UnitedHealth (NYSE:UNH), Humana (NYSE:HUM), and CVS (NYSE:CVS) fell sharply today, with UnitedHealth down 4%, Humana declining 5%, and CVS dropping 4% in afterhours trading. The slide came in response to the Centers for Medicare&Medicaid Services (CMS) announcing a significant expansion of its auditing efforts for Medicare Advantage (MA) plans.
investing.com·1y ago
News Placeholder
Bernstein says market overreacting to Trump order, sees limited new impact on PBMs
Investing.com -- Bernstein analysts say the market has overreacted to President Trump’s latest executive order on drug pricing, arguing that the directive poses limited new risks to pharmacy benefit managers (PBMs) despite a sharp selloff in the sector.
investing.com·1y ago
News Placeholder
CVS Health reward 'positively skewed'
Investing.com -- CVS Health is seeing signs of stabilization in key business areas, prompting Leerink Partners to upgrade the stock from Market Perform to Outperform and raise its price target to $75 per share in a note Thursday. 
investing.com·1y ago
News Placeholder
CVS Health quarterly earnings top estimates amid turnaround push
Investing.com - CVS Health (NYSE:CVS) has posted better-than-anticipated income and revenue in the fourth quarter, as the healthcare group pursues a broad overhaul of its operations under new Chief Executive David Joyner.
investing.com·1y ago
News Placeholder
FTC accuses CVS, Cigna, UnitedHealth of abusing middleman role, shares down
Investing.com -- Shares of CVS Health Corp (NYSE:CVS), Cigna (NYSE:CI) Group, and UnitedHealth Group Inc (NYSE:UNH) were down around 1% after the Federal Trade Commission (FTC) accused their pharmacy benefit manager units of imposing significant price markups on specialty generic drugs, according to a new interim staff report.
investing.com·1y ago
<
...
1
>

Latest CVSM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.